
Exont-based Biopharmaceutical Company Raises $44.9 Million in Initial Public Offering
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) recently announced the full exercise of the underwriters’ option to purchase an additional 487,500 shares of common stock at the public offering price …
Read More